A Phase II Trial of Dexamethasone and 13-Cis-Retinoic Acid [isotretinoin] as First-Line Treatment for Multiple Myeloma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Dexamethasone (Primary) ; Isotretinoin (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 10 Jul 2013 Biomarkers information updated
- 01 Sep 2009 Actual end date (Oct 2005) added as reported by ClinicalTrials.gov.
- 01 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.